These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 32521802)

  • 1. Multimodal Decorations of Mesoporous Silica Nanoparticles for Improved Cancer Therapy.
    Barui S; Cauda V
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32521802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of surface capped mesoporous silica nanoparticles for pH-stimuli responsive drug delivery applications.
    Santha Moorthy M; Bharathiraja S; Manivasagan P; Lee KD; Oh J
    Medchemcomm; 2017 Sep; 8(9):1797-1805. PubMed ID: 30108889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPP-Cu
    Chen W; Ma M; Lai Q; Zhang Y; Liu Z
    Curr Med Chem; 2023; 30(28):3249-3260. PubMed ID: 36221869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
    Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
    Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the stimuli-responsive mesoporous silica nanoparticles as drug delivery system nanotechnology for controlled release and cancer therapy.
    Zhu Y; Bai Y; He J; Qiu X
    3 Biotech; 2023 Aug; 13(8):274. PubMed ID: 37457870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Three-in-One" Multifunctional Gatekeeper Gated Mesoporous Silica Nanoparticles for Intracellular pH-Activated Targeted Cancer Therapy.
    Zhang Y; Wang W; Zhang Y; Cheng M; Wu Q; Yuan Z
    ACS Appl Bio Mater; 2018 Sep; 1(3):572-580. PubMed ID: 34996191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy.
    Moodley T; Singh M
    Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33430390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer.
    Watermann A; Brieger J
    Nanomaterials (Basel); 2017 Jul; 7(7):. PubMed ID: 28737672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
    Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
    J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinase-Responsive Mesoporous Silica Nanoparticles Cloaked with Cleavable Protein for "Self-Actuating" On-Demand Controlled Drug Delivery for Cancer Therapy.
    Vaghasiya K; Ray E; Sharma A; Katare OP; Verma RK
    ACS Appl Bio Mater; 2020 Aug; 3(8):4987-4999. PubMed ID: 35021676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release and intracellular protein delivery from mesoporous silica nanoparticles.
    Deodhar GV; Adams ML; Trewyn BG
    Biotechnol J; 2017 Jan; 12(1):. PubMed ID: 27973750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
    Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
    Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [No Abstract]   [Full Text] [Related]  

  • 20. Supramolecular Nanomachines as Stimuli-Responsive Gatekeepers on Mesoporous Silica Nanoparticles for Antibiotic and Cancer Drug Delivery.
    Cheng CA; Deng T; Lin FC; Cai Y; Zink JI
    Theranostics; 2019; 9(11):3341-3364. PubMed ID: 31244957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.